Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats

References

• Aurbek N, Thiermann H, Szinicz L, Worek F. 2007. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model. Toxicology 233:173–179.
   PubMedGoogle Scholar
• Barton H, Chiu W, Setzer W, Anderson M, Bailer A, Bois F, DeWoskin R, Hays S, Johanson G. 2007. Characterizing uncertainty and variability in physiologically-based pharmacokinetic (PBPK) models: state of science and needs for research and implementation. Toxicol Sci 99:395–402.
   PubMed Web of Science ®Google Scholar
• Bosgra S, Voet HVD, Boon PE, Slob W. 2009. An integrated probabilistic framework for cumulative risk assessment of common mechanism chemicals in food: an example with organophosphorus pesticides. Regul Toxicol Pharmacol 54:124–133.
   PubMed Web of Science ®Google Scholar
• Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407–484.
   PubMed Web of Science ®Google Scholar
• Clement JG. 1984. Role of aliesterase in organophosphate poisoning. Fundam Appl Toxicol 4:S96–S105.
   Google Scholar
• Clewell RA, Clewell HJ 3rd. 2008. Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regul Toxicol Pharm 50:129–143.
   PubMed Web of Science ®Google Scholar
• Ecobichon DJ. 1996. Toxic effects of pesticides. In: Klaassen CD, Amdur MO, Doull J (Eds.), Casarett and Doull’s Toxicology: The basic science of poisons. 5th edn. New York, NY: McGraw-Hill. pp 890–891.
   Google Scholar
• Gearhart JM, Jepson GW, Clewell HJ 3rd, Andersen ME, Conolly RB. 1990. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate. Toxicol Appl Pharmacol 106:295–310.
   PubMed Web of Science ®Google Scholar
• Gearhart JM, Jepson GW, Clewell HJ 3rd, Andersen ME, Conolly RB. 1994. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by organophosphate esters. Environ Health Pers 102(Suppl 11):51–60.
   PubMedGoogle Scholar
• Gomase VS, Tagore S. 2008. Species scaling and extrapolation. Curr Drug Metab 9:193–198.
   PubMed Web of Science ®Google Scholar
• Gosselin NH, Bouchard M. 2005. Toxicokinetic modeling of parathion and its metabolites in humans for the determination of biological reference values. Toxicol Mech Methods 15:33–52.
   Web of Science ®Google Scholar
• Grubic Z, Sketelj J, Klinar B, Brzin M. 1981. Recovery of acetylcholinesterase in the diaphragm, brain, and plasma of the rat after irreversible inhibition by soman: a study of cytochemical localisation and molecular forms of the enzyme in the motor end plate. J Neurochem 37:909–916.
   PubMed Web of Science ®Google Scholar
• Hamby D. 1995. A comparison of sensitivity analysis techniques. Health Phys 68:195–204.
   PubMed Web of Science ®Google Scholar
• Luo Y, Zhang M. 2009. Multimedia transport and risk assessment of organophosphate pesticides and a case study in the northern San Joaquin Valley of California. Chemosphere 75:969–978.
   PubMedGoogle Scholar
• Martin BR. 1985. Biodisposition of [3H]diisopropylfluorophosphate in mice. Toxicol Appl Pharmacol 77:275–284.
   PubMedGoogle Scholar
• Mason HJ, Waine E, Stevenson AJ, Wilson HK. 1993. Aging and spontaneous reactivation of human plasma cholinesterase activity after inhibition by organophosphorus pesticides. Human Exp Toxicol. 12:497–503.
   PubMed Web of Science ®Google Scholar
• Mason HJ. 2000. The recovery of plasma cholinesterase and erythrocyte acetylcholinesterase activity in workers after over-exposure to dichlorvos. Occup Med 5:343–347.
   Google Scholar
• Maxwell DM, Vlahacos CP, Lenz DE. 1988. A pharmacodynamic model for soman in the rat. Toxicol Lett 43:175–188.
   PubMed Web of Science ®Google Scholar
• Michalek H, Meneguz A, Bisso GM. 1982. Mechanisms of recovery of brain acetylcholinesterase in rats during chronic intoxication by isoflurophate. Arch Toxicol Suppl 5:116–119.
   PubMedGoogle Scholar
• Nestorov I. 2007. Whole-body physiologically based pharmacokinetic models. Expert Opin Drug Metab Toxicol 3:235–249.
   PubMed Web of Science ®Google Scholar
• Parkinson A. 1996. Biotransformation of xenobiotics. In: Klaassen CD, Amdur MO, Doull J (Eds.), Casarett and Doull’s Toxicology: The basic science of poisons. 5th edn. New York, NY: McGraw-Hill. pp 175–180.
   Google Scholar
• Rhomberg LR, Lewandowski TA. 2004. Methods for identifying a default cross-species scaling factor. Prepared for Risk Assessment Forum. U.S. Environmental Protection Agency.
   Google Scholar
• Saltelli A, Tarantola S, Campolongo F. 2000. Sensitivity analysis as an ingredient of modelling. Stats Sci. 15:377–395.
   Web of Science ®Google Scholar
• Sweeney RE, Langenberg JP, Maxwell DM. 2006. A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species. Arch Toxicol 80:719–731.
   PubMed Web of Science ®Google Scholar
• Timchalk C, Kousba AA, Poet TS. 2007. An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat. Toxicol Sci 98:348–365.
   PubMed Web of Science ®Google Scholar
• Traina ME, Serpietri LA. 1984. Changes in the levels and forms of rat plasma cholinesterase during chronic diisopropylphosphorofluoridate intoxication. Biochem Pharmacol 33:645–653.
   PubMedGoogle Scholar
• US Environmental Protection Agency. 2006. Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment. EPA/600/R-05/043F.
   Google Scholar
• Worek F, Eyer P, Szinicz L, Thiermann H. 2007. Simulation of cholinesterase status at different scenarios of nerve agent exposure. Toxicology 233: 155–165.
   PubMedGoogle Scholar